A high-fiber, plant-based diet delays progression to multiple myeloma, improves microbiome health, reduces inflammation, and ...

Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & ...

Ciltacabtagene autoleucel achieved a 100% complete response rate in patients with high-risk smoldering multiple myeloma, as ...

At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.

Survival in multiple myeloma has improved significantly with the advent of novel, more potent immunotherapies, including CAR ...

Anita D'Souza, MD, discusses some of the potentially practice-changing data that were presented at the 2024 ASH Annual ...

Bispecific antibodies show strong initial uptake in community settings for multiple myeloma treatment, particularly among ...

Gov. Whitmer called on Michigan residents, businesses, schools, local governments and other organizations to join the tribute ...

The family of Mrs. Judith Jo Nelson are saddened to announce her passing on Thursday, December 5, 2024 at the Meadows in Swift Current, Saskatchewan following a lengthy battle with multiple myeloma.

A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...

Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show ...

A group of seven family and friends took part in the Cardiff Half Marathon and raised £7,000 for the Leri Day Unit at ...